Hot Features
Premium
Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 55,407 |
|
|||||
| News | - | ||||||
| Day High | 1.48 | Low High |
|||||
| Day Low | 1.35 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Altamira Therapeutics Ltd | CYTO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.03 | 2.08% | 1.47 | 09:24:04 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.35 | 1.35 | 1.48 | 1.44 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 326 | 55,407 | US$ 1.41 | US$ 78,219 | - | 1.35 - 28.40 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 09:23:30 | 100 | US$ 1.47 | USD |
Altamira Therapeutics Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.06M | 349.50k | - | 306k | -26.53M | -75.90 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Altamira Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYTO Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.46 | 1.60 | 1.35 | 1.44 | 655,323 | 0.01 | 0.68% |
| 1 Month | 2.41 | 2.49 | 1.35 | 1.62 | 269,308 | -0.94 | -39.00% |
| 3 Months | 1.91 | 3.49 | 1.35 | 2.28 | 1,278,936 | -0.44 | -23.04% |
| 6 Months | 3.396 | 17.20 | 1.35 | 6.79 | 8,568,256 | -1.93 | -56.71% |
| 1 Year | 21.40 | 28.40 | 1.35 | 7.54 | 4,666,918 | -19.93 | -93.13% |
| 3 Years | 1,172.00 | 1,548.00 | 1.35 | 190.64 | 2,688,260 | -1,170.53 | -99.87% |
| 5 Years | 1,172.00 | 1,548.00 | 1.35 | 190.64 | 2,688,260 | -1,170.53 | -99.87% |
Altamira Therapeutics Description
| Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. |
